Surgical treatment for heart failure: cell-based therapy with engineered tissue

Abstract

This review will outline cell-based therapy for heart failure focusing on tissue engineering to deliver cells to the damaged heart. We will present an overview of the central approaches focusing on pluripotent stem cell-derived cells, mechanisms of action, autologous vs. allogeneic cell approaches, immunologic modulation, and safety considerations. We will outline the progress that has been made to-date and define the areas that still need to be investigated in order to advance the field.

Keywords

Heart failure / induced pluripotent stem cells / tissue engineering

References

[1] Thomson JA,Shapiro SS,Swiergiel JJ.Embryonic stem cell lines derived from human blastocysts Science1998;282:1145-7

[2] Yu J,Smuga-Otto K,Antosiewicz-Bourget J.Induced pluripotent stem cell lines derived from human somatic cells..Science2007;318:1917-20

[3] Davis J,Correll RN,Schwanekamp JA.Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy..Cell2016;165:1147-59 PMCID:PMC4874838

[4] Eschenhagen T.Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review..Pflugers Arch2019;471:755-68 PMCID:PMC6475632

[5] Tanaka A,Node K.Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells..Int J Mol Sci2015;16:18894-22 PMCID:PMC4581278

[6] Wang Y,Lan F,Lisooski L.Genome Editing of Isogenic Human Induced Pluripotent Stem Cells Recapitulates Long QT Phenotype for Drug Testing..J Am Coll Cardiol2014;64:451-9 PMCID:PMC4149735

[7] Mummery CL.Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research..Stem Cell Rep2018;11:1306-11 PMCID:PMC6294284

[8] Stillitano F,Kong CW,Funck-Brentano C.Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells..Elife2017;6:e19406 PMCID:PMC5279943

[9] Menasche P,Vilquin JT,Abergel E.Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction..J Am Coll Cardiol2003;41:1078-83

[10] Fisher SA,Mathur A.Meta-Analysis of Cell Therapy Trials for Patients with Heart Failure - An Update..Circ Res2015;116:1361-77

[11] Nguyen PK,Wu JC.Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review..JAMA Cardiol2016;1:831-41 PMCID:PMC5349705

[12] Muller-Ehmsen J,Kloner RA,Sakoda T.Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium..J Mol Cell Cardiol2002;34:107-16

[13] Leor J,Cohen S.Cells, Scaffolds, and molecules for myocardial tissue engineering..Pharmacol Ther2005;105:151-63

[14] Thai HM,Lancaster JJ,Castellano L.Implantation of a three-dimensional fibroblast matric improves left ventricular function and blood flow after acute myocardial infarction..Cell Transplant2009;18:283-95 PMCID:PMC2739416

[15] Lancaster JJ,Hagerty T,Hicks M.Viable fibroblast matric patch induces angiogenesis and increases myocardial blood flow in heart failure after myocardial infarction..Tissue Eng Pt A2010;16:3065-73

[16] Lancaster JJ,Johnson NM,Witte R.An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure..J Heart Lung Transplant2014;33:438-45 PMCID:PMC3966928

[17] Gao L,Jung JP,Zhang P.Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold..Circ Res2017;120:1318-25 PMCID:PMC5392171

[18] Wnorowski A.3-Dimensionally Printed, Native-Like Scaffolds for Myocardial Tissue Engineering..Circ Res2017;120:1224-6 PMCID:PMC5409836

[19] Menasché P,Hagège A,Cholley B.Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction..J Am Coll Cardiol2018;71:429-38

[20] Kawamura M,Miki K,Fukushima S.Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model..Circulation2012;126:S29-37

[21] Schmuck EG,Ertel RL,Ogle BM.Cardiac fibroblast-derived 3D extracellular matrix seeded with mesenchymal stem cells as a novel device to transfer cells to the ischemic myocardium..Cardiovasc Eng Technol2014;5:119-31 PMCID:PMC3964807

[22] Ruan JL,Razumova MV,Pabon L.Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue..Circulation2016;134:1557-67 PMCID:PMC5123912

[23] Zhang J,Radisic M.Can we engineer a human cardiac patch for therapy?.Circ Res2018;123:244-65

[24] Akst J. Available from:https://www.the-scientist.com/news-opinion/donor-derived-ips-cells-show-promise-for-treating-eye-disease-65817#.XMmiehFIHDk.email. [Last accessed on 2 Sep 2019].

[25] Fujita B.Myocardial Tissue Engineering for Regenerative Applications..Curr Cardiol Rep2017;19:78

[26] Pearl JI,Davis MM.Pluripotent stem cells: immune to the immune system?.Sci Transl Med2012;4:164ps25 PMCID:PMC3638038

[27] Cyranoski D.Reprogrammed stem cells approved to mend hearts Japanese study is only the second application of induced pluripotent stem cells in people..Nature2018;557:619-20

[28] Meissner T,Cowan C.The universal donor stem cell: removing the immune barrier to transplantation using CRISPR/Cas9 (TRAN1P.946).J Immunol2015;194:140.28

[29] Gershlaka JR,Fontanac G,Hansen KJ.Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds..Biomaterials2017;125:13-22 PMCID:PMC5388455

[30] Liau B,Leong KW.Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function..Biomaterials2011;32:9180-7 PMCID:PMC3190071

[31] Kim DH,Smith RR,Ahn EH.Nanopatterned cardiac cell patches promote stem cell niche formation and myocardial regeneration..Integr Biol-UK2012;4:1019-33

[32] Jang J,Kim SW,Park JY.3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair..Biomaterials2017;112:264-74

[33] Tsui JH,Yama DMP,Choi JS.Conductive silk-polypyrrole composite scaffolds with bioinspired nanotopographic cues for cardiac tissue engineering..J Mater Chem B2018;6:7185-96 PMCID:PMC6708520

[34] Machiraju P.Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes..World J Stem Cells2019;11:33-43 PMCID:PMC6354100

[35] Lancaster OJ,Repetti GG,Pandey AC.Human Induced Pluripotent Stem Cell–Derived Cardiomyocyte Patch in Rats With Heart Failure..Ann Thorac Surg2019;

[36] Wei K,Hurtado C,Zhao M.Epicardial FSTL1 reconstitution regenerates the adult mammalian heart..Nature2015;525:479-85 PMCID:PMC4762253

[37] Masters M.The epicardium signals the way towards heart regeneration..Stem Cell Res2014;13:683-92 PMCID:PMC4241487

[38] Cao J.The epicardium as a hub for heart regeneration..Nat Rev Cardiol2018;15:631-47 PMCID:PMC6143401

[39] Zimmermann WH,Wasmeier G,Naito H.Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts..Nat Med2006;12:452-8

[40] Matsubayashi K,Mickle DA,Ozawa T.Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts..Circulation.2003;108 Suppl 1:II219-25

[41] Sawa Y,Toda K,Yamazaki K.Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease..Circ J2015;79:991-9

[42] Yoshikawa Y,Toda K,Sakata Y.Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study..Surg Today2018;48:200-10

[43] Yorgan K,Mannhardt I,Ulmer B.Differentiation of cardiomyocytes and generation of human engineered heart tissue..Nat Protoc2017;12:1177-97

[44] Liu J,Wang Z,Wang X.Autologous stem cell transplantation for myocardial repair..Am J Physiol Heart Circ Physiol2004;287:H501-11

[45] Godier-Furnemont AF,Koeckert MS,Parks J.Composite scaffold provides a cell delivery platform for cardiovascular repair..Proc Natl Acad Sci USA2011;108:7974-9 PMCID:PMC3093484

[46] Matsuura K,Shimizu T,Sato F.Creation of human cardiac cell sheets using pluripotent stem cells..Biochem Biophys Res Commun2012;425:321-7

[47] Sasagawa T,Sekiya S,Yamato M.Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology..Biomaterials2010;31:1646-54

[48] Jung JH,Yang PC.Exosomes generated from iPSC-derivatives: new direction for stem cell therapy in human heart diseases..Circ Res2017;120:407-17 PMCID:PMC5260934

[49] Ogle BM,Domian I,Menasché P.Distilling complexity to advance cardiac tissue engineering..Sci Transl Med2016;8:342ps13 PMCID:PMC4959426

[50] Bargher J,Colzani M,Hofsteen P.Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration..Nat Biotechnol2019;37:895-906

[51] Liu YW,Yang X,Kalucki FA.Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates..Nat Biotechnol2018;36:597-605 PMCID:PMC6329375

[52] Romagnuolo R,Porta-Sanchez A,Barry J.Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias..Stem Cell Rep2019;12:967-81 PMCID:PMC6524945

[53] Taylor DA.The Future of Tissue Engineering in Heart Transplantation..Tex Heart Inst J2019;46:73-4 PMCID:PMC6378990

[54] Noor N,Edri R,Wertheim L.Tissue Engineering: 3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts..Adv Sci2019;6:1970066 PMCID:PMC6548966

[55] Huang NF,Morris VB,Pardon G.Big bottlenecks in cardiovascular tissue engineering..Commun Biol2018;1:199 PMCID:PMC6249300

[56] Regenerative Medicine Advanced Therapy Designation. Available from:https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/regenerative-medicine-advanced-therapy-designation. [Last accessed on 2 Sep 2019].